Add Company
Join Now

Regenerative Processing Plant Revenue and Competitors

License our Company Data API

Tampa, FL USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Regenerative Processing Plant's estimated annual revenue is currently $2.5M per year.(i)
  • Regenerative Processing Plant's estimated revenue per employee is $155,000

Employee Data

  • Regenerative Processing Plant has 16 Employees.(i)
  • Regenerative Processing Plant grew their employee count by 7% last year.

Regenerative Processing Plant's People

NameTitleEmail/Phone
1
Head QualityReveal Email/Phone
2
Director Quality ControlReveal Email/Phone
3
Director Government RelationsReveal Email/Phone
4
Director Quality ControlReveal Email/Phone
5
Director Research and DevelopmentReveal Email/Phone
6
Director Regulatory and ComplianceReveal Email/Phone
7
Packaging ManagerReveal Email/Phone
8
Strategic Account ManagerReveal Email/Phone
9
Biotech Sales RepresentativeReveal Email/Phone
10
Quality Assurance Quality ControlReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M995%N/AN/A
#2
$1.1M7-30%N/AN/A
#3
$3.7M244%N/AN/A
#4
$4.3M28-3%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.8M50%N/AN/A
#7
$1.1M70%N/AN/A
#8
$2.5M167%N/AN/A
#9
$1.4M9-25%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is Regenerative Processing Plant?

Transforming Wellness Medicine Through Disruptive Natural Regenerative Medicine Based Products. We offer a wide range of innovative high quality soft tissue and wound care products for tissue regeneration. The science of regenerative healing is the pathway to Regenerative Processing Plant’s (RPP) FIRST STERILE PRODUCT of its kind on the market. Following years of studying and researching biologic birth tissues, RPP believes it has seized the power of the body’s natural healing in its Proprietary Cryo-Activ™ process in its initial disruptive product: PDA –Human Amniotic Fluid Cryo-Activ®. The Company has developed this process for sterilizing human amniotic fluid and has patents on this proprietary procedure which is a differentiated characteristic of the PDA-Human Amniotic Fluid Cryo-Activ®. While other products claim sterility, most are simply processed aseptically utilizing sterile techniques.RPP has a proprietary AmnioCleanse™ process used to Sterilize the product without losing Biological Activities.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M17N/AN/A
#2
$4.5M20-13%N/A
#3
N/A210%N/A
#4
$2.2M22-8%N/A
#5
$2.2M225%N/A